Enveric Biosciences Inc. (ENVB): Price and Financial Metrics
GET POWR RATINGS... FREE!
ENVB Stock Price Chart Interactive Chart >
ENVB Price/Volume Stats
|Current price||$4.40||52-week high||$112.50|
|Prev. close||$4.34||52-week low||$4.13|
|Day high||$4.47||Avg. volume||176,754|
|50-day MA||$6.05||Dividend yield||N/A|
|200-day MA||$16.17||Market Cap||9.14M|
Enveric Biosciences Inc. (ENVB) Company Bio
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from ... More
Most Popular Stories View All
ENVB Latest News Stream
|Loading, please wait...|
ENVB Latest Social Stream
View Full ENVB Social Stream
Latest ENVB News From Around the Web
Below are the latest news stories about ENVERIC BIOSCIENCES INC that investors may wish to consider to help them evaluate ENVB as an investment opportunity.
Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
CAMBRIDGE, Mass., August 31, 2022--Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President & COO of Enveric, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022.
These are the seven psychedelics stocks to buy in September.
If you want to zig while the bears zag, these short-squeeze stocks to put on your radar may make for handsome profits.
Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!
ENVB Price Returns